Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Initiation and Maintenance Disorders 1Neoplasms 1Fatigue 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Has results × Monitoring, Physiologic × Clear all
NCT02613364 2024-05-01

YOCAS-II

University of Rochester

Phase NA Completed
746 enrolled 32 charts

Sleep Initiation and Maintenance Disorders, Neoplasms

NCT02699983 2021-04-13

eHealth Weight Loss Program in African American Breast Cancer Survivors

Rutgers, The State University of New Jersey

Phase NA Completed
35 enrolled 35 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT02688192 2021-04-09

TLCFIT

Rutgers, The State University of New Jersey

Phase NA Completed
49 enrolled 14 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡